DRUG AND GENE DELIVERY DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Drug and Gene Delivery Devices Market, By Product (Sub-retinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Pre-filled Syringe, and Infusion Bags), By Commercialized Drugs (Luxturna, Yescarta, Zolgensma, Kymriah, Provenge, and Strimvelis, By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 26 Mar, 2026
Code: CMI5864
Page number: 155
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Product
  - Market Snapshot, By Commercialized Drugs
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Rise in burden of chronic diseases across the globe
  - Stringent rules and regulations
  - Increasing demand for drug
    
    and gene delivery devices
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Drug and Gene Delivery Devices Market, By Product, 2021 - 2033, (US$ Thousand)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022-2033
  - Segment Trends
- Sub-retinal Injection Cannula
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
- Extension Tube
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
- Intravenous Catheter
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
- Sterile Insulin Syringe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
- Pre-filled Syringe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
- Infusion Bags
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
Global Drug and Gene Delivery Devices Market, By Commercialized Drugs, 2021 - 2033, (US$ Thousand)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022-2033
  - Segment Trends
- Luxturna (Drug Delivery Devices)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
- Yescarta (Drug Delivery Devices)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
- Zolgensma (Drug Delivery Devices)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
- Kymriah (Drug Delivery Devices)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
- Provenge (Drug Delivery Devices)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
- Strimvelis (Drug Delivery Devices)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
Global Drug and Gene Delivery Devices Market, By Region, 2021 - 2033, (US$ Thousand)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022-2033
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Thousand)
  - Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2021 - 2033,(US$ Thousand)
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Thousand)
  - Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2021 - 2033,(US$ Thousand)
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Thousand)
  - Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2021 - 2033,(US$ Thousand)
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Thousand)
  - Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2021 - 2033,(US$ Thousand)
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Thousand)
  - Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2021 - 2033,(US$ Thousand)
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Thousand)
  - Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2021 - 2033,(US$ Thousand)
Competitive Landscape
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Kite Pharma, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bluebird bio, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Vericel Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- uniQure N.V.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Spark Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Renova Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Orchard Therapeutics plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Kolon Tissue Gene, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Human Stem Cell Institute
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Amgen, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Dendreon Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Helixmith Co.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bausch & Lomb Incorporated, Ltd. (ViroMed Co., Ltd.)
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Becton Dickinson and Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Castle Creek Biosciences, Inc. (Fibrocell Technologies, Inc.)
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Analyst Views
Section
- Research Methodology
- About us

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now